EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

On the Boundary of Exploratory Genomics and Translation in Sequential Glioblastoma

Marton Tompa, Bence Galik iD, Peter Urban iD, Bela Istvan Kajtar iD, Zoltan Kraboth, Attila Gyenesei, Attila Miseta, Bernadette Kalman iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25147564 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Marton Tompa und 7 weiteren Autor:innen. Beteiligte Einrichtung: Szentagothai Research Center, University of Pecs, 20. Ifjusag Street, 7624 Pecs, Hungary. Hauptthemen laut MEDLINE: Glioblastoma, Genomics, Exome Sequencing, Brain Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Dr. Janos Szolcsanyi Research Fund by the University of Pecs, School of Medicine, Thematic Excellence Program 2020 National Excellence Sub-program, ELIXIR Converge.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OMICS methods brought significant advancements to the understanding of tumor cell biology, which transformed the treatment and prognosis of several cancers. Clinical practice and outcomes, however, changed significantly less in the case of glioblastoma (GBM). In this study, we aimed to assess the utility of whole exome (WES) sequencing in the clinical setting. Ten pairs of formalin-fixed, paraffin-embedded (FFPE) GBM specimens were obtained at onset (GBM-P) and at recurrence (GBM-R). Histopathological and molecular features of all samples supported the diagnosis of GBM based on WHO CNS5. WES data were filtered, applying a strict and custom-made pipeline, and occurrence of oncogenic and likely oncogenic variants in GBM-P, GBM-R or both were identified by using the VarSeq program version 2.5.0 (Golden Helix, Inc.). Characteristics and recurrence of the variants were analyzed in our own cohort and were also compared to those available in the COSMIC database. The lists of oncogenic and likely oncogenic variants corresponded to those identified in other studies. The average number of these variants were 4 and 5 out of all detected 24 and 34 variants in GBM-P and GBM-R samples, respectively. On average, one shared oncogenic/likely oncogenic variant was found in the pairs. We assessed the identified variants’ therapeutic significance, also taking into consideration the guidelines by the Association for Molecular Pathology (AMP). Our data support that a thorough WES analysis is suitable for identifying oncogenic and likely oncogenic variants in an individual clinical sample or a small cohort of FFPE glioma specimens, which concur with those of comprehensive research studies. Such analyses also allow us to monitor molecular dynamics of sequential GBM. In addition, careful evaluation of data according to the AMP guideline reveal that though therapeutic applicability of the variants is generally limited in the clinic, such information may be valuable in selected cases, and can support innovative preclinical and clinical trials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaGenomicsExome SequencingBrain NeoplasmsHumansMaleFemaleMiddle AgedAgedAdultNeoplasm Recurrence, LocalMutation

Stichwörter der Autor:innen

clinical utilitydeep bioinformaticsglioblastomawhole exome sequencing

Autor:innen und Institutionen

  • Szentagothai Research Center, University of Pecs, 20. Ifjusag Street, 7624 Pecs, Hungary.
  • Department of Molecular Medicine, Markusovszky University Teaching Hospital, 5. Markusovszky Street, 9700 Szombathely, Hungary.
  • Department of Pathology, School of Medicine, University of Pecs, 12. Szigeti Street, 7624 Pecs, Hungary.
  • Office of the Dean, School of Medicine, University of Pecs, 20. Ifjusag Street, 7624 Pecs, Hungary.

ORCID-Profile: Bence Galik, Peter Urban, Bela Istvan Kajtar, Bernadette Kalman

Förderung

  • Dr. Janos Szolcsanyi Research Fund by the University of Pecs, School of Medicine
  • Thematic Excellence Program 2020 National Excellence Sub-program
  • ELIXIR Converge
  • H2020-MSCA-COFUND Marie Skłodowska-Curie
  • University of Pecs, School of Medicine
  • National Research, Development and Innovation Fund of Hungary
  • Polish Ministry of Science and Higher Education

Zitieren

APA

Tompa, M., Galik, B., Urban, P., Kajtar, B. I., Kraboth, Z., Gyenesei, A., Miseta, A., & Kalman, B. (2024). On the Boundary of Exploratory Genomics and Translation in Sequential Glioblastoma. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25147564

Vancouver

Tompa M, Galik B, Urban P, Kajtar BI, Kraboth Z, Gyenesei A, et al. On the Boundary of Exploratory Genomics and Translation in Sequential Glioblastoma. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25147564

BibTeX
@article{Tompa2024,
  author = {Tompa, Marton and Galik, Bence and Urban, Peter and Kajtar, Bela Istvan and Kraboth, Zoltan and Gyenesei, Attila and Miseta, Attila and Kalman, Bernadette},
  title = {On the Boundary of Exploratory Genomics and Translation in Sequential Glioblastoma},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25147564}
}
Kostenlos starten →